Pharma Journalist - Page 25 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Alnylam Expands Massachusetts Facility to Advance RNAi Manufacturing

Phase 3 Trial Shows Survival Gains in Muscle-Invasive Bladder Cancer

Takeda Reports Strong Phase 3 Results for Oral Psoriasis Therapy

FDA Approves First Subcutaneous Therapy for EGFR-Mutated Lung Cancer

FDA Grants Breakthrough Designation to Adrabetadex for Infantile NPC

Telix and Varian Partner to Advance Theranostic-Driven Cancer Care

Zealand Pharma and OTR Therapeutics Launch Collaboration on Metabolic Drugs

Formation Bio Acquires Global Rights to Next-Gen TYK2 Inhibitor

China Approves First New Progressive Pulmonary Fibrosis Drug in 5 Years

Moderna, Nanexa Sign Deal to Develop Long-Acting Injectable Medicines